D-1872-2019 Class II Terminated
FDA drug recall D-1872-2019 was initiated by Aurolife Pharma, LLC on August 23, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated August 16, 2022). Affected quantity: 240 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- September 25, 2019
- Initiation Date
- August 23, 2019
- Termination Date
- August 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 240 bottles
Product Description
Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunswick Pike, Lawrenceville, NJ 08648; NDC 58602-820-09.
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: 067180026A1, Exp 07/21